![](/img/cover-not-exists.png)
PCN72 COST OF MANAGING METASTATIC BLADDER CANCER WITH THE INTRODUCTION OF IMMUNOTHERAPIES FROM A CANADIAN HEALTHCARE PERSPECTIVE
Nazha, S., Tholomier, C., Kassouf, W., Dragomir, A.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.196
Date:
May, 2019
File:
PDF, 382 KB
2019